Log in
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Dynamic quotes 

MarketScreener Homepage  >  Equities  >  Nyse  >  Pfizer Inc.    PFE


SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Pfizer : Health minister says Quebec remains on track to give vaccine booster within 90 days

02/12/2021 | 03:29pm EST

MONTREALQuebec's health minister says the province remains on track to administer a second dose of COVID-19 vaccine within the 90-day time frame recommended by public health authorities.

Christian Dube told a legislative committee on health care Friday that given the problems with vaccine supply, he is glad health officials recommended delaying the second of two required doses.

“With the problems we had with vaccine delivery, I don’t think anyone contests that choice and the decision,” Dube said. “We will respect this engagement to give the second dose within the delay public health has prescribed.”

Liberal health critic Marie Montpetit raised the vaccine-delay issue, noting it was 61 days since the province's inoculation campaign started on Dec. 14.

In January, Quebec announced it would wait up to 90 days before giving a COVID-19 vaccine booster to people who had received a first shot, in order to maximize the number of residents getting at least one vaccination.

The delay went beyond recommendations of vaccine manufacturers Pfizer and Moderna — creators of the only two vaccines so far approved by Health Canada — which proposed intervals of 21 and 28 days, respectively. Quebec's plan was also more than double the 42-day maximum delay proposed by Canada’s national vaccine advisory committee.

Dube said authorities are keeping tabs on those who got a first dose to ensure they're doing well.

The province administered 7,927 doses of COVID-19 vaccine Thursday, for a total of 280,612, which represents about 2.9 per cent of Quebec's population. The province has so far received slightly more than 310,000 doses.

Dube said he was hesitant to promise a firm vaccination schedule because of the uncertainty around supply. On Friday, the Trudeau government said Canada is expected to receive 84 million doses from Pfizer and Moderna by the end of September.

Quebec's plan to vaccinate seniors living in private residences has been disrupted by the shipment slowdown. Dube said he would like to be able to tell those groups when they'll be vaccinated but can't.

“We won’t make promises we can’t keep,” Dube said.

Earlier Friday, Montreal surpassed 100,000 reported COVID-19 infections, but hospitalizations across the province continued their downward trend, dropping 25, to 849. There were also six fewer patients in intensive care, for a total of 137. Hospitalizations have fallen by 120 over the past four reporting periods.

Health officials reported 984 new COVID-19 cases and 25 more deaths attributed to the novel coronavirus, including four in the past 24 hours. They said Quebec had 10,657 active reported cases.

Montreal remained the region with the most new, daily reported infections in Quebec, with 432 cases reported Friday, for a total of 100,203. The city has recorded 4,434 deaths linked to the virus.

Dube said authorities remain concerned about three variants of the virus, two of which have been detected in Quebec so far.

Dube has said the province will ramp up screening positive cases in Montreal for variants next week. He has also said health officials will allocate more vaccine resources to Montreal and that the premier is considering imposing more restrictions for Quebec's spring break week, which begins March 1.

Quebec has reported a total of 274,831 infections and 10,173 deaths linked to the virus.

This report by The Canadian Press was first published Feb. 12, 2021.

© 2021 The Canadian Press. All rights reserved., source Canadian Press DataFile

Stocks mentioned in the article
ChangeLast1st jan.
MODERNA, INC. 4.33% 154.81 Delayed Quote.48.19%
PFIZER INC. -0.98% 33.49 Delayed Quote.-8.12%
All news about PFIZER INC.
01:27aASIA TODAY : S. Korea allows workers to squeeze extra doses
02/26Panel urges US regulators to approve single-dose Covid-19 vaccine
02/26J&J Single-Dose Covid-19 Vaccine Gains Backing From FDA Advisory Panel -- 4th..
02/26J&J Single-Dose Covid-19 Vaccine Gains Backing From FDA Advisory Panel -- 3rd..
02/26Health Care Down On Growth Doubts -- Health Care Roundup
02/26PFIZER : Scammers Are Setting Up Fake Covid Vaccine Websites
02/26PFIZER : Panama vaccinating disabled people against Covid-19
02/26MARKET CHATTER : Johnson & Johnson Says COVID-19 Vaccine Tied to Severe Allergic..
02/26WARREN BUFFETT : Warren Buffett's Annual Letter Is About to Land
02/26FDA advisory panel to review Johnson & Johnson COVID-19 vaccine with thumbs u..
More news
Financials (USD)
Sales 2020 48 014 M - -
Net income 2020 16 066 M - -
Net Debt 2020 42 982 M - -
P/E ratio 2020 11,9x
Yield 2020 4,38%
Capitalization 186 B 186 B -
EV / Sales 2020 4,77x
EV / Sales 2021 3,60x
Nbr of Employees 88 300
Free-Float 59,0%
Duration : Period :
Pfizer Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends PFIZER INC.
Short TermMid-TermLong Term
Income Statement Evolution
Mean consensus OUTPERFORM
Number of Analysts 23
Average target price 41,04 $
Last Close Price 33,49 $
Spread / Highest target 58,3%
Spread / Average Target 22,5%
Spread / Lowest Target 7,49%
EPS Revisions
Managers and Directors
Albert Bourla Chairman, Chief Executive & Operating Officer
Frank A. D'Amelio Chief Financial Officer & EVP-Business Operations
Lidia L. Fonseca Executive VP, Chief Digital & Technology Officer
Rady A. Johnson Chief Compliance & Risk Officer, Executive VP
Suzanne Nora Johnson Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
PFIZER INC.-8.12%186 208
JOHNSON & JOHNSON0.69%427 844
ROCHE HOLDING AG-3.87%281 904
NOVARTIS AG-5.51%197 388
ABBVIE INC.0.55%189 532
MERCK & CO., INC.-11.22%188 791